Common Contracts
3 similar Warrant Agent Agreement contracts by BriaCell Therapeutics Corp., GeoVax Labs, Inc., Heart Test Laboratories, Inc.
WARRANT AGENT AGREEMENTWarrant Agent Agreement • June 23rd, 2022 • Heart Test Laboratories, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
WARRANT AGENT AGREEMENT (this “Warrant Agreement”) dated as of June 17, 2022 (the “Issuance Date”) between Heart Test Laboratories, Inc., a Texas corporation (the “Company”), and American Stock Transfer & Trust Company, LLC, a New York limited liability trust company (the “Warrant Agent”).
WARRANT AGENT AGREEMENTWarrant Agent Agreement • September 29th, 2020 • GeoVax Labs, Inc. • Pharmaceutical preparations • New York
WARRANT AGENT AGREEMENT (this “Warrant Agreement”) dated as of September 29, 2020 (the “Issuance Date”) between GeoVax Labs, Inc., a company incorporated under the laws of the State of Delaware (the “Company”), and American Stock Transfer & Trust Company, LLC, a New York limited liability trust company (the “Warrant Agent”).
WARRANT AGENT AGREEMENTWarrant Agent Agreement • January 23rd, 2020 • BriaCell Therapeutics Corp. • Pharmaceutical preparations • New York
Notwithstanding the foregoing in this Section 2(a), a holder whose interest in this Warrant is a beneficial interest in certificate(s) representing this Warrant held in book-entry form through DTC (or another established clearing corporation performing similar functions), shall effect exercises made pursuant to this Section 2(a) by delivering to DTC (or such other clearing corporation, as applicable) the appropriate instruction form for exercise, complying with the procedures to effect exercise that are required by DTC (or such other clearing corporation, as applicable). In such case, the rights of any beneficial owner in a Warrant evidenced by the Global Certificate shall be exercised by the Holder or a Participant through the DTC system, except to the extent set forth herein or in the Global Certificate, and the Warrant Agent shall give effect to the written certification, proxy or other authorization furnished by DTC governing the exercise of the rights of a holder of a beneficial i
